Skip to main content
. Author manuscript; available in PMC: 2010 Apr 29.
Published in final edited form as: Int J Cancer. 2009 Aug 1;125(3):680–687. doi: 10.1002/ijc.24369

Figure 1.

Figure 1

Relationship of IgE level in blood among cases and the length of time between diagnosis and blood draw. A. Series 3 patients, no temozolomide treatment. B: Series 3 patients who are on temozolomide therapy. Mean and standard error are shown. Using a general linear model, the trend of IgE was not significantly different among the three categories in no temozolomide treatment, (A, p = 0.15), but significant among the temozolomide-treated (B, p = 0.001).

HHS Vulnerability Disclosure